NRG Energy Inc vs BIO-TECHNE Corp — how do they compare? NRG Energy Inc trades at $132.3 (market cap $27.55B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: NRG Energy Inc is far larger — about 2.5× BIO-TECHNE Corp's market cap, and NRG Energy Inc pays the higher dividend (1.46%). Which is the better fit depends on your goals.
| NRG | TECH | |
|---|---|---|
Market Cap | $27.55B | $11.16B |
Sector | Utilities | Health |
52-Week High | $184.03 | $72.12 |
52-Week Low | $120.65 | $43.31 |
Enterprise Value | $51.38B | $11.24B |
Dividend Yield | 1.46% | 0.45% |
Trailing returns across standard periods
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →